Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.
PERTUSSIS SUMMARY OF PEP POST EXPOSURE PROPHYLAXIS (PEP)
Post-exposure chemoprophylaxis (PEP) <ul><li>People with the highest priority for PEP include:  </li></ul><ul><li>1) close...
Post-exposure chemoprophylaxis (PEP) INDICATIONS <ul><li>CDC and AAP recommend PEP for all close contacts (of confirmed ca...
Postexposure Prophylaxis  <ul><li>Administration of postexposure prophylaxis to asymptomatic household contacts  within 21...
Tx is the same for  Symptomatic Pertussis & PEP <ul><li>Azithromycin.  Adults: 500 mg on day 1, followed by 250 mg per day...
Close contact definition <ul><li>Those who have had direct contact with respiratory, oral or nasal secretions from a sympt...
High risk   ( for severe pertussis disease  ) Contact Definition <ul><li>Contacts at high risk for severe pertussis diseas...
Upcoming SlideShare
Loading in …5
×

Pertussis pep

617 views

Published on

  • Be the first to comment

  • Be the first to like this

Pertussis pep

  1. 1. PERTUSSIS SUMMARY OF PEP POST EXPOSURE PROPHYLAXIS (PEP)
  2. 2. Post-exposure chemoprophylaxis (PEP) <ul><li>People with the highest priority for PEP include: </li></ul><ul><li>1) close contacts in household, childcare, and healthcare settings; </li></ul><ul><li>2) close contacts at high risk for severe disease and adverse outcomes; </li></ul><ul><li>3) close contacts who may transmit disease to persons at high risk for severe disease; </li></ul><ul><li>4) and close contacts in group settings where close interactions occur (e.g., after-school care groups, playgroups, groups of close friends, teammates, etc.). </li></ul>
  3. 3. Post-exposure chemoprophylaxis (PEP) INDICATIONS <ul><li>CDC and AAP recommend PEP for all close contacts (of confirmed cases) , regardless of age or immunization status. </li></ul><ul><li>Starting PEP ≥3 weeks after exposure to an infectious case is probably of no benefit to the contact. </li></ul>
  4. 4. Postexposure Prophylaxis <ul><li>Administration of postexposure prophylaxis to asymptomatic household contacts within 21 days of onset of cough in the index patient ,can prevent symptomatic infection. </li></ul><ul><li>PEP recommended for all household close contacts of confirmed cases </li></ul><ul><li>Coughing (symptomatic) household members of a pertussis patient should be treated as if they have pertussis. </li></ul><ul><li>Low Threshold for PEP in exposure settings that include infants aged <12 months or women in the third trimester of pregnancy </li></ul>
  5. 5. Tx is the same for Symptomatic Pertussis & PEP <ul><li>Azithromycin. Adults: 500 mg on day 1, followed by 250 mg per day on days 2--5. </li></ul><ul><li>Clarithromycin . Adults: 500 mg po bid for 7 days. </li></ul><ul><li>Erythromycin . Erythromycin estolate 500 mg po qid x 14 days </li></ul><ul><li>Alternate agent (TMP--SMZ). Bactrim DS 1tab po bid x 14 days </li></ul>
  6. 6. Close contact definition <ul><li>Those who have had direct contact with respiratory, oral or nasal secretions from a symptomatic case (catarrhal or paroxysmal stages), e.g., a cough or sneeze in the face, sharing food/eating utensils, kissing </li></ul><ul><li>Performing a medical examination of the nose and throat ( without mask / gloves ) </li></ul><ul><li>Sharing a confined space in close proximity for a prolonged period of time (≥1 hour) with a symptomatic case. </li></ul>
  7. 7. High risk ( for severe pertussis disease ) Contact Definition <ul><li>Contacts at high risk for severe pertussis disease and adverse outcomes include: </li></ul><ul><li>1 ) Contacts who may transmit pertussis to a high risk person (healthcare or childcare workers) </li></ul><ul><li>2 ) Pregnant or recently post-partum women </li></ul><ul><li>3 ) Infants <6 months of age, especially premies </li></ul><ul><li>4 ) Unimmunized infants and children </li></ul><ul><li>5 ) Persons with neuromuscular disease </li></ul><ul><li>6 ) Persons who have severe underlying disease such as chronic lung disease or cystic fibrosis or immunocompromised </li></ul>

×